At this point, the use of ACE-inhibiting drugs seems to be safe in COVID-19, and even though most patients suffering from COVID-19 take ACE-inhibitors this seems to be a confounding factor, as the underlying disease that these medications are prescribed for such as hypertension play a far bigger role for adverse outcomes in COVID-19 [48]. This evidence concerns the gene ACE and COVID-19.